Is Kao Corporation profitable in 2026?

Yes. Kao reported FY2025 operating income of ¥164.1 billion, up 11.9% YoY, with net income attributable to owners of ¥120.1 to 120.6 billion, up 11.4% YoY, as of December 31, 2025. Gross margin rose to 39.6%, its highest in years.

Could AI replace Kao Corporation's business?

Unlikely. Kao's moat rests on proprietary surfactant and formulation chemistry, physical manufacturing, and direct-to-retailer distribution in Japan, none displaceable by AI models. Kao instead uses AI internally, e.g. its My Kao Mall recommender, and was named a DX Stock 2026 by Japan's METI/TSE on May 21, 2026.

Is Kao Corporation laying off workers?

Headcount is shrinking modestly. Kao's own filings show 31,514 consolidated employees as of December 31, 2025, down 2,743 (-8.01%) year over year per stockanalysis.com, though Kao's cost-reduction programs, not mass layoffs, drive the decline.

Who is Kao Corporation's biggest competitor?

Globally Kao competes with Unilever and Procter & Gamble, both far larger by revenue and headcount. In Japan's shampoo market specifically, Unilever Japan leads, Kao holds second place, and P&G is third, per an April 2024 trade-press report.

Is Kao Corporation facing activist investor pressure?

Yes. Oasis Management pushed for an independent palm-oil supply-chain review via an Extraordinary General Meeting on April 30, 2026; the proposal got 30.30% support and was rejected, despite proxy advisor ISS recommending in favor on April 16, 2026.

Is Kao Corporation's cosmetics business turning around?

It appears to be. Six focus brands including SENSAI and Kanebo grew 113% YoY versus a roughly flat market in FY2025, and segment operating income exceeded ¥10 billion after years of losses, though Kao's ¥400 billion, 15% margin target isn't due until after 2030.

Consumer brands · Japan

Kao Corporation

kao.com ↗

Japanese maker of household, hygiene, and cosmetics brands like Bioré and Curél.

Defensible for now

Assessed 23 July 2026 · Evidence as of 23 July 2026

Real protection, with named pressure against it.

On the recordSince 23 July 2026 · Checkable from November 2026 · Every call on the record Checkpoint: Q3 FY2026 earnings show whether the cosmetics turnaround holds

The call

Kao is a slow-growing giant whose real test is whether its cosmetics comeback keeps going or fades once the recall and activist noise settle.

Kao makes soaps, shampoos, diapers, and industrial chemicals, selling mostly in Japan through direct relationships with retailers and using its own recipe technology that is hard for competitors to copy quickly. Unilever and Procter and Gamble are already in this space but have not knocked Kao out, and artificial intelligence is not an immediate threat to physical product manufacturing. The real question is whether Kao's new beauty brands, which grew 113 percent last year, can keep that momentum going or if that was just a lucky year, because the company's success over the next few years depends almost entirely on proving this business is real and durable.

Why

AI pressure: None apparent. AI tools could speed up formulation and marketing, but nothing yet threatens shelf space or retailer relationships in Japan. Could AI do the core job? Unlikely.

Bigger players: Unilever and Procter & Gamble. Both outspend Kao globally in cosmetics and skincare, pushing into the same premium categories Kao is trying to grow. Could a giant copy it? Probably.

What protects it. Direct ties to Japanese retailers and decades of surfactant and formulation patents that are hard to copy fast.

What would change this call

Kao Q3 2026 earnings (~Nov 2026) cosmetics segment growth rate. shows whether the +113% brand growth was durable or a one-year anomaly.
Scope of Oribe Serene Scalp shampoo recall and related US litigation outcomes. indicates whether the quality issue is contained or a systemic manufacturing problem.
Oasis Management activity at Kao's next AGM. shows whether activist pressure escalates into forced strategic change.

Key numbers

FY2025 net sales: ¥1,688.6 billion, up 3.7% (2025-12-31)
Cosmetics six focus brands grew 113% YoY (2025-09-29)
Gross margin recovered to 39.6% (2025-12-31)

Named risks

Activist investor Oasis Management may escalate 'Protect Kao' campaign at next AGM after April 2026 EGM rejection. Severity: medium
Oribe shampoo recall (June 30, 2026) could expand into broader manufacturing quality issue. Severity: medium
Cosmetics Business turnaround could stall before post-2030 ¥400 billion, 15% margin target is reached. Severity: medium
Active US litigation against Kao USA (Chiplinsky and Esparza suits, filed 2025-2026) with undisclosed exposure. Severity: low
MSCI ESG downgrade from AA to A in March 2026 signals reputational and governance friction. Severity: low

Rivals, as read in July 2026

Rival	Direction	Evidence
Unilever	losing to	Unilever Japan leads shampoo market with Kao second as of April 2024
Procter & Gamble	contesting	P&G holds third place in Japan shampoo market behind Unilever and Kao, 2024
Unicharm	losing to	Unicharm reported ROE of roughly 14-15% versus Kao's recovering ~10%, per Jan 2026 analyst piece
Shiseido	contesting	Both compete across Japan's cosmetics and premium skincare categories, per 2026 market reports

Questions people ask

Is Kao Corporation profitable in 2026?: Yes. Kao reported FY2025 operating income of ¥164.1 billion, up 11.9% YoY, with net income attributable to owners of ¥120.1 to 120.6 billion, up 11.4% YoY, as of December 31, 2025. Gross margin rose to 39.6%, its highest in years.
Could AI replace Kao Corporation's business?: Unlikely. Kao's moat rests on proprietary surfactant and formulation chemistry, physical manufacturing, and direct-to-retailer distribution in Japan, none displaceable by AI models. Kao instead uses AI internally, e.g. its My Kao Mall recommender, and was named a DX Stock 2026 by Japan's METI/TSE on May 21, 2026.
Is Kao Corporation laying off workers?: Headcount is shrinking modestly. Kao's own filings show 31,514 consolidated employees as of December 31, 2025, down 2,743 (-8.01%) year over year per stockanalysis.com, though Kao's cost-reduction programs, not mass layoffs, drive the decline.
Who is Kao Corporation's biggest competitor?: Globally Kao competes with Unilever and Procter & Gamble, both far larger by revenue and headcount. In Japan's shampoo market specifically, Unilever Japan leads, Kao holds second place, and P&G is third, per an April 2024 trade-press report.
Is Kao Corporation facing activist investor pressure?: Yes. Oasis Management pushed for an independent palm-oil supply-chain review via an Extraordinary General Meeting on April 30, 2026; the proposal got 30.30% support and was rejected, despite proxy advisor ISS recommending in favor on April 16, 2026.
Is Kao Corporation's cosmetics business turning around?: It appears to be. Six focus brands including SENSAI and Kanebo grew 113% YoY versus a roughly flat market in FY2025, and segment operating income exceeded ¥10 billion after years of losses, though Kao's ¥400 billion, 15% margin target isn't due until after 2030.

Timeline

2026-06-30Kao USA voluntarily recalls Oribe Serene Scalp Densifying Shampoo lots for bacterial contamination
2026-05-21Kao named DX Stock 2026 by Japan's METI and TSE for AI-centered management strategy
2026-05-12Q1 2026 results: net sales ¥413.2 billion, EPS ¥68.53, up 39.3% YoY
2026-04-30Oasis Management's EGM palm-oil review proposal rejected with 30.30% support
2026-04-16ISS recommends in favor of Oasis proposal; Kao board publicly opposes
2026-03-23MSCI downgrades Kao's ESG rating from AA to A amid activist dispute
2026-02-06Kao announces 2-for-1 stock split effective July 1, 2026, and 37th dividend increase
2026-02-05FY2025 full-year results released; FY2026 guidance of ¥1,750.0 billion sales set
2025-09-29Kao unveils Cosmetics Business overhaul targeting ¥400 billion sales post-2030
2025-01-01Consumer Products Business renamed Global Consumer Care Business

Head to head

Kao Corporation vs Kose Corporation Kao Corporation vs Rohto Pharmaceutical Co., Ltd.

Revision history

23 July 2026

First assessed. Defensible for now. The text above is fixed as of this date and is not edited afterwards.

In the same band

Estée Lauder LVMH Moet Hennessy Louis Vuitton Chow Sang Sang Holdings International Limited